Fundraising Fox

Stephan Christgau

Investor

Founding Partner at EIR Ventures

Copenhagen

About

Holds a PhD in protein chemistry and immunology and has broad executive experience in private and public biotech. A founding member of Novo Seeds at Novo Holdings, he has led the creation and funding of over 30 Nordic life science companies over nearly 20 years.

Contact· self-published, not guessed

Experience

  1. GutCRINE ApSChairpersoncurrent2023 — present
  2. HenlezChairpersoncurrent2022 — presentCopenhagen, Capital Region of Denmark, Denmark
  3. Scenic BiotechDirectorcurrent2022 — present
  4. Eir VenturesFounding Partnercurrent2020 — present
  5. OctarineChairpersoncurrent2020 — present
  6. Venture CupChairman of the Boardcurrent2012 — presentCopenhagen Metropolitan Area
  7. ISD-ImmunotechMember Board Of Directors2021 — 2023Denmark
  8. Galecto BiotechBoard Member2011 — 2022Kalmar County, Sweden
  9. AFYX TherapeuticsBoard Member2017 — 2020Copenhagen Metropolitan Area
  10. ForendoChairman of the Board2013 — 2020Turku, Finland
  11. HeparegenixBoard Member2016 — 2019Greater Tubingen Area
  12. IO BiotechMember Board of Directors2016 — 2019Copenhagen Metropolitan Area
  13. Macrophage PharmaMember Board Of Directors2016 — 2019
  14. Novo A/SSenior Partner2007 — 2019Copenhagen Metropolitan Area
  15. Acesion PharmaBoard Member2015 — 2019Copenhagen Area, Denmark
  16. LYSOGENEBoard Member2014 — 2018Greater Paris Metropolitan Region
  17. NMD PharmaMember of the Board of Directors2016 — 2017
  18. Adenium BiotechBoard Member2011 — 2017Copenhagen Metropolitan Area
  19. Aros PharmaChairman of the Board2009 — 2015Copenhagen Metropolitan Area
  20. InagenDirector2008 — 2015Copenhagen Metropolitan Area

Skills & more

Product Development27Protein Chemistry17Project Management13Venture Financing25Biotechnology99Lifesciences66Clinical Development41Venture Capital60R&D6Drug Development57Entrepreneurship17Licensing4
+10 moreCorporate DevelopmentDrug DiscoveryBusiness StrategyMergers & AcquisitionsStart-upsTechnology TransferClinical ResearchBiopharmaceuticalsPharmaceutical IndustryStrategy

Languages Danish · English

From Stephan's professional profile.

Deals · 1

Damora TherapeuticsBoard seat

via EIR Ventures · filed Nov 2020 · $64.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at EIR Ventures

Frequently asked questions

Who is Stephan Christgau?
Holds a PhD in protein chemistry and immunology and has broad executive experience in private and public biotech. A founding member of Novo Seeds at Novo Holdings, he has led the creation and funding of over 30 Nordic life science companies over nearly 20 years.
Where does Stephan Christgau work?
Stephan Christgau is Founding Partner at EIR Ventures.
What boards does Stephan Christgau sit on?
Stephan Christgau holds tracked board seats at Damora Therapeutics.
Where did Stephan Christgau go to school?
Stephan Christgau studied at DTU - Technical University of Denmark; University of California, San Francisco (Biochemistry); Harvard Business School (Strategic Negotiation).

Same school

Shared employers